Company Filing History:
Years Active: 1995-1997
Title: Innovator Mark Lee Shenkin: Pioneering Advances in Flow Cytometry
Introduction
Mark Lee Shenkin, an accomplished inventor based in Pembroke Pines, Florida, has made significant contributions to the field of flow cytometry. With a total of two patents to his name, Shenkin focuses on innovative methods that enhance the analysis of blood samples and particles in suspension, showcasing his expertise and dedication to advancing medical science.
Latest Patents
Shenkin's latest patents include a groundbreaking process for detecting reticulocytes and a novel method for determining particle count in a flow cytometer. The first patent, titled "Detection of Reticulocytes," introduces a unique process that employs coriphosphine O to stain reticulocytes, allowing for effective detection through flow cytometry techniques. This innovation enables clinicians to better understand the reticulocyte population in blood samples, which can be critical for diagnosing various blood disorders.
The second patent, "Method and Materials for Determining Particle Count in a Flow Cytometer," presents a method to ascertain the total number of cells per unit volume in a specimen without measuring the volume of the suspension during analysis. This technique involves mixing known quantities of particles with the cell specimen, which then travel through a light beam, producing forward light scattering patterns. The method not only counts the cells and particles but also incorporates adjustments to ensure optimal instrument performance, enhancing accuracy in cellular analysis.
Career Highlights
Shenkin is currently affiliated with Coulter Corporation, a leader in the development of medical laboratory instruments and reagents. His work at Coulter has allowed him to apply his innovative ideas in practical settings, driving advancements in medical diagnostics through improved flow cytometry technologies.
Collaborations
In his pursuit of innovation, Shenkin collaborates with notable colleagues, including Ronald M. Hamelik. Working alongside such professionals enhances the quality and breadth of research conducted, fostering an environment where inventive ideas can flourish and lead to impactful technological advancements.
Conclusion
Mark Lee Shenkin’s contributions to the field of flow cytometry underscore his status as a visionary inventor. His patents not only reflect his innovative spirit but also have the potential to greatly enhance the accuracy of medical diagnoses. As he continues to push the boundaries of scientific exploration, Shenkin remains a valuable asset to the medical and research communities.